Patterns of Hematologic Function and Cytokine Release Syndrome Severity in ALL Patients Receiving CAR-T and TCR-T Therapies Using Pooled Clinical Trial Data

被引：0
|
作者：
Agarwal, Vibhu [1 ]
Socolov, Alexandru [1 ]
Buderi, Robert [1 ]
Rusli, Emelly [1 ]
Bouzit, Lilia [1 ]
Talwai, Aniketh [1 ]
Itzkovich, Yahav [1 ]
Galaznik, Aaron [1 ]
Aptekar, Jacob [1 ]
机构：
[1] Dassault Systemes Co, Medidata Acorn AI, New York, NY 10017 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149180
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4826
引用
收藏
页数：4
相关论文
共 50 条
  • [21] The Dual PI3Kdg Inhibitor Duvelisib Potently Inhibits Cytokine Release Syndrome (CRS) While Maintaining CAR-T Function
    Amatya, Parmeshwar N.
    Jayasinghe, Reyka G.
    Carter, Alun J.
    Cooper, Matthew L.
    Pachter, Jonathan A.
    DiPersio, John F.
    Ritchey, Julie K.
    BLOOD, 2022, 140 : 12686 - 12687
  • [22] Case Report: Clinical and Serological Hallmarks of Cytokine Release Syndrome in a Canine B Cell Lymphoma Patient Treated With Autologous CAR-T Cells
    Atherton, Matthew J.
    Rotolo, Antonia
    Haran, Kumudhini P.
    Mason, Nicola J.
    FRONTIERS IN VETERINARY SCIENCE, 2022, 9
  • [23] Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium
    Jacobs, Miriam T.
    Jain, Michael D.
    Gao, Feng
    Nastoupil, Loretta J.
    Spiegel, Jay Y.
    Lin, Yi
    Dahiya, Saurabh
    Lunning, Matthew
    Lekakis, Lazaros
    Reagan, Patrick M.
    Oluwole, Olalekan O.
    McGuirk, Joseph
    Deol, Abhinav
    Sehgal, Alison
    Goy, Andre
    Hill, Brian T.
    Andreadis, Charalambos
    Munoz, Javier
    Chavez, Julio C.
    Bennani, N. Nora
    Rapoport, Aaron P.
    Vose, Julie M.
    Miklos, David B.
    Neelapu, Sattva S.
    Ghobadi, Armin
    Locke, Frederick L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (10): : 753 - 759
  • [24] Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy
    Shuyi Ding
    Rongrong Chen
    Linqin Wang
    Cheng Zu
    Xiaoyu Zhou
    Jianli Zhang
    Mingming Zhang
    Aiyun Jin
    Tingting Wang
    Yongxian Hu
    BMC Cancer, 23
  • [25] Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy
    Ding, Shuyi
    Chen, Rongrong
    Wang, Linqin
    Zu, Cheng
    Zhou, Xiaoyu
    Zhang, Jianli
    Zhang, Mingming
    Jin, Aiyun
    Wang, Tingting
    Hu, Yongxian
    BMC CANCER, 2023, 23 (01)
  • [26] Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies
    Shalabi, Haneen
    Sachdev, Vandana
    Kulshreshtha, Amita
    Cohen, Julia W.
    Yates, Bonnie
    Rosing, Doug R.
    Sidenko, Stanislav
    Delbrook, Cindy
    Mackall, Crystal
    Wiley, Brandon
    Lee, Daniel W.
    Shah, Nirali N.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [27] Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19
    Diorio, Caroline
    Shraim, Rawan
    Myers, Regina
    Behrens, Edward M.
    Canna, Scott
    Bassiri, Hamid
    Aplenc, Richard
    Burudpakdee, Chakkapong
    Chen, Fang
    DiNofia, Amanda M.
    Gill, Saar
    Gonzalez, Vanessa
    Lambert, Michele P.
    Leahy, Allison Barz
    Levine, Bruce L.
    Lindell, Robert B.
    Maude, Shannon L.
    Melenhorst, J. Joseph
    Newman, Haley
    Perazzelli, Jessica
    Seif, Alix E.
    Lacey, Simon F.
    June, Carl H.
    Barrett, David M.
    Grupp, Stephan A.
    Teachey, David T.
    CLINICAL CANCER RESEARCH, 2022, 28 (17) : 3804 - 3813
  • [28] Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells
    Galli, Eugenio
    Sora, Federica
    Hohaus, Stefan
    Fresa, Alberto
    Pansini, Ilaria
    Autore, Francesco
    Metafuni, Elisabetta
    Innocenti, Idanna
    Limongiello, Maria Assunta
    Giammarco, Sabrina
    Laurenti, Luca
    Bacigalupo, Andrea
    Chiusolo, Patrizia
    De Stefano, Valerio
    Sica, Simona
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (01) : 86 - 94
  • [29] Multi-centers experience using therapeutic plasma exchange for corticosteroid/tocilizumab-refractory cytokine release syndrome following CAR-T therapy
    Pu, Yedi
    Zhao, Yifan
    Qi, Yuekun
    Liu, Yang
    Zhang, Meng
    Xiao, Xia
    Lyu, Hairong
    Meng, Juanxia
    Zhu, Haibo
    Xu, Kailin
    Han, Weidong
    Zhao, Mingfeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 130
  • [30] Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with acute lymphoblastic leukemia
    Kulshrestha, Amita
    Shalabi, Haneen
    Sachdev, Vandana
    Rosing, Douglas
    Sidenko, Stanislav
    Mackall, Crystal
    Wiley, Brandon
    Lee, Daniel
    Shah, Nirali
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345